For personal use only

Similar documents
ANNOUNCEMENT. One for Eight Pro-rata Renounceable Rights Issue at $6.50 per share ("Issue")

ENTITLEMENT OFFER BOOKLET

Attached is a letter sent to Eligible Retail Shareholders in respect of the Retail Entitlement Offer.

Entitlement offer booklet

For personal use only

For personal use only

For personal use only

For personal use only

Chalmers Limited Information Memorandum

For personal use only

ENTITLEMENT OFFER LETTER TO SECURITY HOLDERS

Tabcorp announces a special dividend and capital raising

Dimerix Holdings Limited Entitlement Offer notice to Shareholders

IOOF launches Share Purchase Plan

ACN OFFER DOCUMENT

For personal use only

NON-RENOUNCEABLE RIGHTS ISSUE TO RAISE UP TO $2.57 MILLION

RETAIL ENTITLEMENT INFORMATION BOOKLET

PROSPECTUS. AXIOM MINING LIMITED (ARBN ) (Company)

For personal use only

APA GROUP RETAIL ENTITLEMENT OFFER

Retail Entitlement Offer

Nufarm successfully completes institutional entitlement offer

RETAIL OFFER BOOKLET INVESTORS. Mike Lynn W: M: E:

16 July The Manager Company Announcements Australian Securities Exchange Ltd 20 Bridge Street Sydney NSW 2000.

Not for release to US wire services or distribution in the United States

Steadfast reports 1H FY15 Results and announces Equity Raising for Acquisitions

For personal use only

AJ Lucas Group Limited Retail Entitlement Offer

For personal use only

ASX ANNOUNCEMENT paragoncare.com.au

Engenco announces $85.2 million capital raising

NON-RENOUNCEABLE RIGHTS ISSUE

DESPATCH OF SHARE PURCHASE PLAN OFFER DOCUMENT

This is an important document and requires your immediate attention.

For personal use only

NEXTDC Limited ACN

Appendix 3B. Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

INSURANCE AUSTRALIA GROUP LIMITED ( IAG ) SHARE PURCHASE PLAN

Please find attached a copy of the letter which has been sent to the Company s Shareholders today advising details of the Company s rights issue.

Appendix 3B. Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Off-market Buy-Back booklet

Sonic Healthcare opens Share Purchase Plan

For personal use only

ANZ CAPITAL NOTES 2 PROSPECTUS

For personal use only

Key information in connection with the Rights Offer and important dates are set out below for your reference:

15 July AUTHIER PROJECT ACQUISITION AND A$7.1 million CAPITAL RAISING HIGHLIGHTS

For personal use only

NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES BANK OF QUEENSLAND LIMITED ABN

Appendix 3B. Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

RIGHTS ISSUE OFFER TO SHAREHOLDERS WITH ATTACHED FREE OPTION

ABN Suite 202, 22 St Kilda Rd St Kilda, VIC 3182, Australia

For personal use only

PROSPECTUS. Joint Lead Managers and Underwriters. Bendigo and Adelaide Bank Limited ABN AFSL

Burson Group Limited (ASX: BAP)

ABN OFFER DOCUMENT. for

For personal use only

For personal use only

For personal use only

ASX ANNOUNCES $553 MILLION PRO RATA ACCELERATED RENOUNCEABLE ENTITLEMENT OFFER AND INCREASED INVESTMENT IN ITS CLEARING HOUSES

The SPP provides Eligible Shareholders with the opportunity to purchase New Shares at an issue price which is the lesser of:

For personal use only

For personal use only

ENTITLEMENT OFFER RETAIL INFORMATION BOOKLET

For personal use only

For personal use only

For personal use only

For personal use only

1 for 11 non-renounceable pro-rata entitlement offer of up to approximately million New Securities at $2.30 per New Security

Appen Limited ACN

For personal use only

SHARE BUY-BACK. Buy-back Booklet INSURANCE AUSTRALIA GROUP LIMITED ABN

NOTIFICATION OF EXPIRY OF LISTED OPTIONS

For personal use only

Off-Market Buy-Back Booklet. Woolworths Limited A.B.N THIS IS AN IMPORTANT DOCUMENT

Appendix 3B. Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003, 24/10/2005.

For personal use only

Strategic Acquisition of Daniels Health Australia and Entitlement Offer

OFF-MARKET BUY-BACK BOOKLET. Insurance Australia Group Limited.

Brambles announces decision to retain Recall and A$448M pro rata entitlement offer

For personal use only

For personal use only

For personal use only

Appendix 3B. New issue announcement, application for quotation of additional securities and agreement

SANTOS LIMITED OFF-MARKET BUY-BACK BOOKLET

ASX RELEASE 9 March 2017 METALLICA FULLY FUNDS WEIPA BAUXITE MINE

IPH Limited (ASX: IPH) ( IPH ) announced its intention to conduct a Share Purchase Plan ( SPP ) on Tuesday, 24 November 2015.

For personal use only

Santos Limited Off-market buy-back booklet

For personal use only

ISSUE OF PLACEMENT SHARES AND UPDATE TO SECURITY PURCHASE PLAN TIMETABLE

For personal use only

For personal use only

WHITEFIELD LTD BONUS SHARE PLAN

For personal use only

For personal use only

Appendix 3B. New issue announcement, application for quotation of additional securities and agreement

These documents are provided to ASX in accordance with Listing Rule 3.17 for announcement to the market today.

For personal use only

Transcription:

DIVERSIFIED UNITED INVESTMENT LIMITED ABN 33 006 713 177 LEVEL20 TEL (613) 9654 0499 101 COLLINS STREET FAX (613) 9654 3499 MELBOURNE VIC 3000 AUSTRALIA 7 October 2014 Australian Securities Exchange Level 4 North Tower, Rialto 525 Collins Street Melbourne Vic 3000 ANNOUNCEMENT One for Five Pro-rata Renounceable Rights Issue at $3.00 per share ("Issue") The Directors have resolved to make a renounceable rights issue of approximately 34,303,284 fully paid ordinary shares ("New Shares") in Diversified United Investment Limited ("DUI"). The offer will be made to existing shareholders on a one for five basis at an offer price of $3.00 per New Share payable in full on application ("Entitlement Offer"). The New Shares will not be entitled to receive the interim dividend in respect of the year ending 30 June 2015, expected to be paid in March 2015, after which time the New Shares will rank equally with existing shares. The issue of New Shares is intended to raise approximately $102,609,852 after allowing for the estimated costs of the Issue. Full details of the Entitlement Offer will be set out in an Entitlement Offer Booklet which will be sent to all shareholders who are eligible to participate in the Issue on or around 15 October 2014, together with a personalised Entitlement and Acceptance Form. Rights trading will occur from 9 October 2014 to 24 October 2014 and the Entitlement Offer will close at 5.00pm on 31 October 2014. The Directors see advantages in the Company raising additional funds in order to invest in new opportunities and to re-balance the portfolio without having to sell long-term investments. The Issue will also provide shareholders with the opportunity to increase their investment in the Company, improve liquidity in the trading of the Company's shares and lower the management expense ratio. When the funds are received from the issue of New Shares the Company is likely to move its international investments target allocation from 5% towards 10% of the portfolio. This will enable the Company to increase its exposure to world equity markets and, in particular, world technology companies and a broader range of companies in the health sector, including the major pharmaceutical companies. At 30 September 2014 international investments represented approximately 3% of the portfolio. To the extent the Company invests internationally it is likely to invest in securities with lower dividend yields than from the Australian market and dividends to shareholders are therefore more likely to be steady rather than increasing over the next few years. Funds raised from the offer will however introduce more diversification into the portfolio and potential for greater capital appreciation. The Board expects to maintain the current interim dividend rate for existing shares of 6.5 cents per share in respect of the year ending 30 June 2015 and expects, in the absence of unforeseen circumstances, to maintain the current annual dividend rate of 14 cents per share on the increased capital.

2 The unaudited estimated pre tax net tangible assets of the Company on 6 October 2014 was $3.69 per share, before providing for the interim dividend in respect of the year to 30 June 2015 to which the New Shares will not be entitled. The offer price of $3.00 per New Share represents a discount of 16% to the latest available market sale price of existing shares on the ASX of $3.56 on 6 October 2014. Shareholder approval of the Issue is not required. The Directors have been advised by The Ian Potter Foundation Ltd as trustee for both The Ian Potter Foundation and the George Alexander Foundation that it intends to subscribe for its entitlement to the Issue in full (including the Entitlement of its controlled entity, Dundee Trading Pty Ltd) in the absence of unforeseen circumstances. Terms of Issue The New Shares will not be entitled to receive the interim dividend in respect of the year ending 30 June 2015, expected to be paid in March 2015, and accordingly the first dividend receivable on the New Shares will be the final dividend in respect of the year ending 30 June 2015, expected to be paid in September 2015. If permission is given for official quotation, the New Shares will trade under a separate ASX code (expected to be "DUIN") until the existing shares trade ex the interim dividend payable in respect of the year ending 30 June 2015 when the New Shares will trade under the Company's ASX Code of 'DUI' for existing shares and will rank equally in all respects with existing shares. Placing Agents The Issue is not underwritten. Evans and Partners Pty Ltd and Dixon Advisory & Superannuation Services Limited are Placing Agents to the Issue. Dividends and Underlying Earnings per share Dividends paid and underlying earnings per share in respect of each of the last 5 completed financial years are as follows: Year Ended Dividends Underlying Earnings 30 June (cents per share) (cents per share) 2014 14.0 15.0 2013 13.5 13.5 2012 13.0 13.1 2011 13.0 12.5 2010 13.0 11.1 Underlying earnings per share exclude both special dividends received by the Company and net realised capital gains or losses on long term investments. All dividends referred to above were fully franked. The balance of the Company s franking account at 30 June 2014 (after adjusting for the final dividend paid on 25 September 2014) was $10,117,250. It is the Directors' expectation that both the next interim dividend (not to be paid on the New Shares) and the final dividend for the year ending 30 June 2015 will be fully franked.

3 Investment Performance The Company s performance (assuming all dividends paid by the Company were re-invested in its shares) is as follows: Periods Ended 30 June 2014 DUI Net Asset Backing Accumulation DUI Share Price Accumulation S&P ASX 300 Accumulation Index 1 Year 20.1 25.1 17.3 3 Years 11.8 15.2 10.0 5 Years 11.9 11.7 11.0 10 Years 10.4 11.4 9.0 Record date for Entitlements to New Shares Shareholders will be entitled to one New Share for every five existing shares held as at the Record Date ("Entitlement"). In calculating Entitlements to New Shares, fractional Entitlements will be rounded up to the nearest whole share. Shares held on separate sub-registers for the same holder will not be aggregated. If Shareholders have more than one registered holding of existing shares, they will be sent a personalised Entitlement and Acceptance Form for each separate holding. Information on dealing with your Entitlement is set out below. Share capital on completion of the Issue On completion of the Issue, on the assumption that it is fully subscribed, the share capital of the Company will be approximately 205,819,705 shares, comprising 171,516,421 existing shares and approximately 34,303,284 New Shares. The Company has no unquoted securities. Rights Trading Trading in rights to the New Shares will begin on the Australian Stock Exchange ("ASX") on 9 October 2014 and cease on 24 October 2014. The closing date for acceptances and payment of $3.00 for each New Share is 5.00pm AEDT on 31 October 2014. Who is eligible to participate Shareholders with addresses in Australia and New Zealand who are not in the United States or a U.S. Person or acting for or on account of U.S. Persons are eligible to participate ("Eligible Shareholders").

4 Shareholders with addresses in countries other than Australia and New Zealand will not be eligible to participate because the Company has decided it is not reasonable to offer securities to persons in other countries having regard to the number of shareholders in each country, the number and value of the securities that would be offered to them and the cost of complying with the laws of such other country. However, DUI will appoint a nominee to act on its behalf to seek to arrange for the sale of the Entitlements of those shareholders and to pay such shareholders the net proceeds of sale (if any) in Australian dollars. Dealing with your Entitlement if you are an Eligible Shareholder Existing shareholders receive 1 renounceable right to one New Share for every five existing shares held on the Record Date. Eligible Shareholders may choose to apply for all or some of their Entitlement, sell some or all of their Entitlements (subject to the availability of buyers), or do nothing. The Entitlements will trade on the Australian Securities Exchange during the rights trading period under a separate ASX code. If you wish to sell all or part of your Entitlements you should contact your broker or other professional advisor during that period. Should you wish to purchase additional rights to New Shares during the rights trading period, please contact your broker or other professional advisor. To accept all or part of your Entitlement your completed Entitlement and Acceptance Form must be lodged with DUI's Share Registry (whose address will be on the Form) by 5.00pm AEDT on 31 October 2014 together with a cheque (or payment can be made by BPay) for the amount due in respect of the New Shares taken up. To transfer your Entitlement to another person, you should complete a standard renunciation form (obtainable from your broker or other professional advisor or the Share Registry) and send it with the Entitlement and Acceptance Form to the Share Registry by 5.00pm AEDT on 31 October 2014. Process for dealing with Shortfall To the extent that Entitlements are not taken up ("Shortfall") they may be placed, at the discretion of the Company after the conduct of a bookbuild by the Placing Agents, to Eligible Shareholders or new professional or sophisticated investors. Any net proceeds from such sale (being the gross proceeds from the sale less the offer price and the fees and other costs of the Placing Agents) will be distributed in due proportion among the shareholders whose entitlements were neither sold nor taken up. Neither the Company nor the Placing Agents will be liable for any failure to arrange for the issue of any New Shares in respect of Entitlements neither sold nor taken up by the closing date at a particular price or time, or at all. As there can be no guarantee that there will be any net proceeds, it is important that Eligible Shareholders take action either to take up or sell their Entitlements. Should you wish to purchase additional New Shares through the Shortfall bookbuild, please contact either of the Placing Agents, whose contact details will be in the Corporate Directory in the Entitlement Offer Booklet.

5 Indicative timetable Rights trading commences and ordinary shares quoted ex rights Thursday 9 October 2014 Record Date to determine Entitlements to New Shares 7.00pm Monday 13 October 2014 Despatch of Entitlement Offer Booklet to Eligible Shareholders Wednesday 15 October 2014 Last day of rights trading Friday 24 October 2014 New Shares quoted on a deferred settlement basis Monday 27 October 2014 Closing date for receipt of applications (and/or renunciations) and payment 5.00pm Friday 31 October 2014 Shortfall Bookbuild (if any) Wednesday 5 November 2014 Announcement of Shortfall (if any) Thursday 6 November 2014 Issue of New Shares Monday 10 November 2014 Issuer Sponsored Statements for New Shares despatched 10 November 2014 Normal trading of New Shares expected to commence Tuesday 11 November 2014 This timetable is indicative only. The Company reserves the right to vary the above dates without notice subject to the Corporations Act, Listing Rules and any other applicable law. Any amendments to the timetable will be announced on ASX. Times are AEDT. Shareholders should read the Entitlement and Offer Booklet carefully when they receive it and consult their broker or other professional adviser to evaluate whether or not to participate in the Entitlement Offer. A J Hancock Company Secretary